Search Results - "Chikkala, NF"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene by Gautam, SC, Chikkala, NF, Hamilton, TA

    Published in The Journal of immunology (1950) (01-03-1992)
    “…We examined the effects of IL-4, a cytokine produced by Th2 cells, on the development of an Ag-specific, T cell-mediated inflammatory response in a…”
    Get full text
    Journal Article
  3. 3

    In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS by Villinger, F, Bucur, S, Chikkala, N F, Brar, S S, Bostik, P, Mayne, A E, Adams, J, Lee, M E, Novembre, F J, Gately, M K, Ansari, A A, Hillyer, C D

    Published in AIDS research and human retroviruses (20-05-2000)
    “…The in vitro proliferative responses of macaque peripheral blood mononuclear cells (PBMCs) to IL-12 appeared similar before and early after SIV infection,…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Interactive effects of α-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity : analysis at the effector and precursor level by CHIKKALA, N. F, LEWIS, I, ULCHAKER, J, STANLEY, J, TUBBS, R, FINKE, J. H

    Published in Cancer research (Chicago, Ill.) (15-02-1990)
    “…Studies from our laboratory and others have demonstrated that alpha-interferon (IFN alpha) can regulate natural killer cells and lymphokine-activated killer…”
    Get full text
    Journal Article
  6. 6

    Immune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS by Villinger, Francois, Brar, Sukhdev S., Brice, Gary T., Chikkala, Nathaniel F., Novembre, Francis J., Mayne, Ann E., Bucur, Silvana, Hillyer, Christopher D., Ansari, Aftab A.

    Published in Journal of medical primatology (01-02-1997)
    “…: Until recently, chimpanzees were considered susceptible to human immunodeficiency virus type 1 (HIV‐1) infection, but refractory to disease induction based…”
    Get full text
    Journal Article
  7. 7

    Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population by Gautam, S C, Chikkala, N F, Battisto, J R

    Published in Cellular immunology (01-02-1990)
    “…Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting…”
    Get more information
    Journal Article
  8. 8

    Combination therapy with adriamycin and interleukin 2 augments immunity against murine renal cell carcinoma by Gautam, S C, Chikkala, N F, Ganapathi, R, Hamilton, T A

    Published in Cancer research (Chicago, Ill.) (15-11-1991)
    “…The mechanism(s) through which combination treatment with Adriamycin and recombinant interleukin 2 (rIL2) affects murine renal cell carcinoma was investigated…”
    Get full text
    Journal Article
  9. 9

    Expression and in vitro evaluation of rhesus macaque wild type (wt) and modified CC chemokines by Bostik, Pavel, Villinger, Francois, Brice, Gary T., Chikkala, Nathaniel F., Brar, Sukhdev S., Cruikshank, William W., Adams, Jonathan W., Hillyer, Christopher D., Ansari, Aftab A.

    Published in Journal of medical primatology (01-04-1998)
    “…: Several human CC chemokines have been shown to inhibit HIV/SIV infection in vitro, providing the rationale for their potential use in vivo. However, because…”
    Get full text
    Journal Article
  10. 10

    Differences in murine gut-associated lymphoid tissues in generating broadly nonspecific cytotoxic cells in response to interferon alpha A/D and interleukin 2 by Chikkala, N F, Gautam, S C

    Published in Cellular immunology (01-07-1991)
    “…We examined the response of cells of murine gut-associated lymphoid tissues to agents that augment the activity of natural killer (NK) cells. Specifically, we…”
    Get more information
    Journal Article
  11. 11

    Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma by Gautam, S C, Chikkala, N F, Lewis, I, Grabowski, D R, Finke, J H, Ganapathi, R

    Published in Anticancer research (01-05-1992)
    “…Development of multidrug-resistance (MDR) remains a major cause of failure in the treatment of cancer with chemotherapeutic agents. In our efforts to explore…”
    Get more information
    Journal Article